← Leaderboards
Mayra S. Tisminetzky
Univ Of Massachusetts Med Sch Worcester
$2,391,686
Attributed
$2,391,686
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $692.3K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,391,686 · 1
By mechanism
R01$2,391,686 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- William R Kobertz$10,727,331
- Wenjun Li$12,063,314
- Lawrence J Hayward$2,740,299
- Jerry H Gurwitz$26,233,444
- Elisabeth Bloch Salisbury$3,514,511
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAdverse OutcomeAffectAge-YearsAgingAnemiaAngiotensin-Converting Enzyme InhibitorsAngiotensin Ii ReceptorBaseBradycardiaCardiovascular SystemCaringCessation Of LifeChronicChronic Kidney FailureClinical EffectivenessClinical ManagementClinical Practice GuidelineClinical TrialsCohortCommon TreatmentCommunitiesComorbidityAdrenergic Beta-Antagonists
Grant awards (4)
Multimorbidity and Treatment-Related Outcomes in Older Heart Failure Patients$474,177
R01 · FY2022 · AG · contact PI
Multimorbidity and Treatment-Related Outcomes in Older Heart Failure Patients$642,994
R01 · FY2021 · AG · contact PI
Multimorbidity and Treatment-Related Outcomes in Older Heart Failure Patients$582,245
R01 · FY2020 · AG · contact PI
Multimorbidity and Treatment-Related Outcomes in Older Heart Failure Patients$692,270
R01 · FY2019 · AG · contact PI